Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125284651 | 12528465 | 1 | I | 20160627 | 20160705 | 20160705 | EXP | IE-DSJP-DSE-2016-121870 | DAIICHI | PRENDERGAST C, EGAN L. OLMESARTAN INDUCED DUODENITIS AS A CAUSE OF VILLOUS ATROPHY. IRISH JOURNAL OF MEDICAL SCIENCE. 2015;184 (SUPPL 7):264 | 0.00 | Y | 0.00000 | 20160705 | OT | IE | IE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125284651 | 12528465 | 1 | PS | OLMESARTAN MEDOXOMIL. | OLMESARTAN MEDOXOMIL | 1 | Oral | UNK, QD | U | 21286 | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125284651 | 12528465 | 1 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125284651 | 12528465 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125284651 | 12528465 | Abdominal pain | |
| 125284651 | 12528465 | Diarrhoea | |
| 125284651 | 12528465 | Intestinal villi atrophy | |
| 125284651 | 12528465 | Malabsorption | |
| 125284651 | 12528465 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |